[Changes in the sensitivity of clinical strains of Staphylococcus aureus caused by cefamandole, cefoperazone and 6-alpha-bromopenicillanic acid sulfone in vitro].
Jastalska
D
D
Lupicki
W
W
Zapaśnik
M
M
Pajchel
G
G
Chojnowski
W
W
D002435:Cefamandole / Q000494:pharmacology*; D002438:Cefoperazone / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D066298:In Vitro Techniques; D010397:Penicillanic Acid / Q000494:pharmacology* / Q000031:analogs & derivatives; D013211:Staphylococcus aureus / Q000187:drug effects*
D002435:Cefamandole; C018008:brobactam; D002438:Cefoperazone; D010397:Penicillanic Acid
Zmiany wrazliwości klinicznych szczepów Staphylococcus aureus wywołane cefamandolem, cefoperazonem i sulfonem kwasu 6-alfa-bromopenicylanowego in vitro.